Viewing nowHyunab Tablet 30 mg (Pimasartan Potassium Trihydrate)
Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
HanKook Hytex Pharmaceutical Co., Ltd.

MFDS item code 202402895 · Approved 2024.12.06 · Insurance code 649106050
Treatment of essential hypertension
Essential hypertension is a condition where blood pressure remains consistently elevated, and this medication is used to effectively manage essential hypertension.
⦁ Adults The recommended dose of this medication is 30 ~ 60 milligrams once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, the dose may be increased to 120 milligrams once daily. It is recommended that the medication be taken at the same time each day, if possible (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks ~ 12 weeks. ⦁ Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. For elderly patients over 70 years of age, an initial dose of 30 mg of this medication once daily is recommended. (See section 9. Administration to elderly patients under Precautions for Use.) ⦁ Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment at 30 milligrams once daily and do not exceed 60 milligrams per day. ⦁ Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medication should not be administered to patients with moderate ~ severe hepatic impairment (see sections 2. Patients Who Must Not Receive This Medication and 10. Administration to Patients with Hepatic Impairment under Precautions for Use). ⦁ Patients with reduced effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at increased risk of hypotension, such as those with reduced effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Administration with Caution under Precautions for Use.)
⦁ Children The safety and efficacy of this medication have not been established in pediatric and adolescent patients 18 years of age or younger.
This medication may cause serious harm to the fetus or newborn if taken during pregnancy, especially in the second and third trimesters, so if pregnancy is confirmed, it should be stopped immediately. This medication should not be used by individuals allergic to its components, pregnant women, breastfeeding women, patients on kidney dialysis, patients with moderate to severe liver impairment, or patients with bile duct obstruction. Patients with reduced blood volume or salt deficiency, impaired kidney function, renal artery hypertension, aortic or heart valve issues, and primary aldosteronism should exercise special caution when using this medication. When taking this medication, symptoms such as headache and dizziness may commonly occur, and more rarely, dyspepsia, vomiting, skin rashes, myalgia, and hypotension may occur; if unusual symptoms appear, consult a physician immediately. If blood pressure drops too low or severe side effects occur, stop taking the medication and seek appropriate treatment. Interactions may occur when taken with other antihypertensives, diuretics, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc.; thus, consulting a physician or pharmacist is essential. It is advisable to avoid taking this medication if pregnant or breastfeeding; if necessary, breastfeeding or medication should be discontinued. It is recommended not to use this medication in children under 18 years of age as safety and efficacy have not been established. Elderly patients aged 65 and older may react more sensitively to this medication; caution is advised during use, although dosage adjustment is typically not necessary. Patients with moderate to severe liver impairment should not use this medication, and mild liver impairment patients should take it while closely monitoring their condition. In case of overdose, hypotension and cardiac rhythm abnormalities may occur, so immediate medical attention is required. This medication should be kept out of the reach of children and should not be transferred to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it is best to store it at a temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's efficacy.
Pale green, oval-shaped film-coated tablet with rounded edges
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowFimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
HanKook Hytex Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 132.02mg
Tablet · Prescription medication
Boryung Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Boryung Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Korea Hyutex Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Dongkuk Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.